Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Durable SARS-CoV-2 B cell immunity after mild or severe disease
Clinton O. Ogega, … , Andrea L. Cox, Justin R. Bailey
Clinton O. Ogega, … , Andrea L. Cox, Justin R. Bailey
Published February 11, 2021
Citation Information: J Clin Invest. 2021;131(7):e145516. https://doi.org/10.1172/JCI145516.
View: Text | PDF
Research Article Immunology Infectious disease Article has an altmetric score of 41

Durable SARS-CoV-2 B cell immunity after mild or severe disease

  • Text
  • PDF
Abstract

Multiple studies have shown loss of severe acute respiratory syndrome coronavirus 2–specific (SARS-CoV-2–specific) antibodies over time after infection, raising concern that humoral immunity against the virus is not durable. If immunity wanes quickly, millions of people may be at risk for reinfection after recovery from coronavirus disease 2019 (COVID-19). However, memory B cells (MBCs) could provide durable humoral immunity even if serum neutralizing antibody titers decline. We performed multidimensional flow cytometric analysis of S protein receptor binding domain–specific (S-RBD–specific) MBCs in cohorts of ambulatory patients with COVID-19 with mild disease (n = 7), and hospitalized patients with moderate to severe disease (n = 7), at a median of 54 days (range, 39–104 days) after symptom onset. We detected S-RBD–specific class-switched MBCs in 13 of 14 participants, failing only in the individual with the lowest plasma levels of anti–S-RBD IgG and neutralizing antibodies. Resting MBCs (rMBCs) made up the largest proportion of S-RBD–specific MBCs in both cohorts. FCRL5, a marker of functional memory on rMBCs, was more dramatically upregulated on S-RBD–specific rMBCs after mild infection than after severe infection. These data indicate that most SARS-CoV-2-infected individuals develop S-RBD–specific, class-switched rMBCs that resemble germinal center–derived B cells induced by effective vaccination against other pathogens, providing evidence for durable B cell–mediated immunity against SARS-CoV-2 after mild or severe disease.

Authors

Clinton O. Ogega, Nicole E. Skinner, Paul W. Blair, Han-Sol Park, Kirsten Littlefield, Abhinaya Ganesan, Santosh Dhakal, Pranay Ladiwala, Annukka A.R. Antar, Stuart C. Ray, Michael J. Betenbaugh, Andrew Pekosz, Sabra L. Klein, Yukari C. Manabe, Andrea L. Cox, Justin R. Bailey

×

Total citations by year

Year: 2025 2024 2023 2022 2021 Total
Citations: 3 5 16 23 24 71
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (71)

Title and authors Publication Year
Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19
Kumar D, Gaikwad K, Gunnale R, Vishwakarma S, Shukla S, Srivastava S, Gopal J, Vaidya B, Saraf A, Gurjar R, Kaviraj S, Singh A, Raghuwanshi A, Agarwal P, Savergave L, Singh S
NPJ Vaccines 2025
Time course and determinants of the antibody response to SARS-CoV-2 in Costa Rica: the RESPIRA study
Herrero R, Fantin R, Loría V, Aparicio A, Prevots DR, Zúñiga M, Wong R, Morera M, Butt J, Binder M, Abdelnour A, Calderón A, Castro R, Cortes B, Ocampo R, Vanegas JC, Gail MH, Pfeiffer RM, Flock J, Remans K, Eberhardt L, Rastgou S, Magalhaes V, Porras C, Hildesheim A, Waterboer T
BMC Infectious Diseases 2025
Efficient boosting of Omicron-reactive memory B cells after breakthrough infection protects from repeated exposure
Chu Q, Li K, He Q, Ren L, Wang J, Wang S, Liu X, Liu Y, He J, Li D, Shao Y
iScience 2025
Poor immune response to inactivated COVID-19 vaccine in patients with hypertension
Yang L, Zeng T, Li Y, Guo Q, Jiang D
Frontiers in Medicine 2024
Differences in phenotype between long-lived memory B cells against Plasmodium falciparum merozoite antigens and variant surface antigens
Reyes RA, Turner L, Ssewanyana I, Jagannathan P, Feeney ME, Lavstsen T, Greenhouse B, Bol S, Bunnik EM
2024
Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles
Serwanga J, Oluka GK, Baine C, Ankunda V, Sembera J, Kato L, Katende JS, Odoch G, Auma BO, Gombe B, Musenero M, Kaleebu P
PloS one 2024
Atypical and non-classical CD45RB(lo) memory B cells are the majority of circulating SARS-CoV-2 specific B cells following mRNA vaccination or COVID-19.
Priest DG, Ebihara T, Tulyeu J, Søndergaard JN, Sakakibara S, Sugihara F, Nakao S, Togami Y, Yoshimura J, Ito H, Onishi S, Muratsu A, Mitsuyama Y, Ogura H, Oda J, Okusaki D, Matsumoto H, Wing JB
Nature Communications 2024
Differences in phenotype between long-lived memory B cells against Plasmodium falciparum merozoite antigens and variant surface antigens
Reyes RA, Turner L, Ssewanyana I, Jagannathan P, Feeney ME, Lavstsen T, Greenhouse B, Bol S, Bunnik EM
PLOS Pathogens 2024
Cellular and Humoral Responses to Recombinant and Inactivated SARS-CoV-2 Vaccines in CKD Patients: An Observational Study
Zhang S, He J, Tang B, Zhou Q, Hu Y, Yu Y, Chen J, Liu Y, Li C, Ren H, Liao X
Journal of Clinical Medicine 2023
A FluoroSpot B assay for the detection of IgA and IgG SARS-CoV-2 spike-specific memory B cells: Optimization and qualification for use in COVID-19 vaccine trials
Bisceglia H, Barrier J, Ruiz J, Pagnon A
Journal of Immunological Methods 2023
Multivariate indicators of disease severity in COVID-19
Bean J, Kuri-Cervantes L, Pennella M, Betts MR, Meyer NJ, Hassan WM
Scientific Reports 2023
Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2.
Zurbuchen Y, Michler J, Taeschler P, Adamo S, Cervia C, Raeber ME, Acar IE, Nilsson J, Warnatz K, Soyka MB, Moor AE, Boyman O
Nature Immunology 2023
Immune responses to inactivated COVID-19 vaccine were decreased in Chinese patients with chronic respiratory diseases
Yang L, Xu L, Guo Q, Deng B, Hong Y, Wang L, Wang Y, Jiang D, Ren H
International journal of medical sciences 2023
Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection
Wang H, Liu C, Xie X, Niu M, Wang Y, Cheng X, Zhang B, Zhang D, Liu M, Sun R, Ma Y, Ma S, Wang H, Zhu G, Lu Y, Huang B, Su P, Chen X, Zhao J, Wang H, Shen L, Fu L, Huang Q, Yang Y, Wang H, Wu C, Ge W, Chen C, Huo Q, Wang Q, Wang Y, Geng L, Xie Y, Xie Y, Liu L, Qi J, Chen H, Wu J, Jiang E, Jiang W, Wang X, Shen Z, Guo T, Zhou J, Zhu P, Cheng T
Immunity 2023
SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity
Mohn KG, Bredholt G, Onyango TB, Brokstad KA, Zhou F, Holter JC, Tonby K, Dyrhol-Riise AM, Cox RJ
Journal of Infection 2023
Humoral immune responses to inactivated COVID-19 vaccine up to 1 year in children with chronic hepatitis B infection
Zhou Y, Chen Z, He Y, Peng X, Chang Y, Tan A, Li H, Cai D, Hu P, Chen M, Peng M, Xu H, Ren H
Frontiers in Cellular and Infection Microbiology 2023
Seroprevalence of SARS-CoV-2 immunoglobulin G antibody during COVID-19 pandemic in Fayoum District, Egypt: a community-based pilot survey.
Bakr S, Ezzat EM, Salem KM, Masoud M, Abdelaziz HEM
The Pan African medical journal 2023
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells.
Krause RGE, Moyo-Gwete T, Richardson SI, Makhado Z, Manamela NP, Hermanus T, Mkhize NN, Keeton R, Benede N, Mennen M, Skelem S, Karim F, Khan K, Riou C, Ntusi NAB, Goga A, Gray G, Hanekom W, Garrett N, Bekker LG, Groll A, Sigal A, Moore PL, Burgers WA, Leslie A
npj Vaccines 2023
Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 Messenger Ribonucleic Acid Vaccines in Infected Individuals: A Systematic Review
Roslan M, Mohd Nisfu FR, Arzmi MH, Abdul Wahab R, Zainuddin N
The Malaysian Journal of Medical Sciences : MJMS 2023
The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
Yang L, Liu Y, Guo Q, Jiang D
Open Medicine 2023
Immunological changes in a cohort of COVID-19 survivors: Mansoura University experience
Elhadidy T, Abdelwahab HW, Shahin D, Hewidy A, Khashaba E, Elmorsey RA, Abo El Kheir N, Eid EA, El-Mesery A, Elmaria MO
F1000Research 2023
Immunological changes in a cohort of COVID-19 survivors: Mansoura University experience.
Elhadidy T, Abdelwahab HW, Shahin D, Hewidy A, Khashaba E, Elmorsey RA, Abo El Kheir N, Eid EA, El-Mesery A, Elmaria MO
F1000Research 2023
Dynamic Humoral Immune Response to Primary and Booster Inactivated SARS-CoV-2 Vaccination in Patients with Cirrhosis.
Zhu Q, Wang L, Hu X, Zhang Y, Huang T, He T, Chen Z, Zhang G, Peng M, Chen M, Cai D, Shi X, Ren H
Journal of Clinical and Translational Hepatology 2023
Safety and Immunogenicity After Primary and Booster Inactivated SARS-Cov-2 Vaccination in Patients with Autoimmune Liver Diseases
Chen Z, Wang Y, He T, Li H, Ao L, Pan Q, Zhou Y, Zhu Q, Xiang D, Zhang G, Ling N, Chen M, Hu P, Peng M, Cai D, Zhang D, Ren H
Journal of Clinical and Translational Hepatology 2023
SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralising antibodies
Anna Jeffery-Smith, Alice R. Burton, Sabela Lens, Chloe Rees-Spear, Jessica Davies, Monika Patel, Robin Gopal, Luke Muir, Felicity Aiano, Katie Doores, J. Yimmy Chow, Shamez N Ladhani, Maria Zambon, Laura McCoy, Mala K Maini.
Journal of Clinical Investigation 2022
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients
N Khoo, J Lim, U Gill, R de Alwis, N Tan, J Toh, J Abbott, C Usai, E Ooi, J Low, N Bert, P Kennedy, A Bertoletti
The American Journal of Medicine 2022
Continued Virus-Specific Antibody-Secreting Cell Production, Avidity Maturation and B Cell Evolution in Patients Hospitalized with COVID-19
M Bartlett, S Suwanmanee, N Akindele, S Ghimire, A Chan, C Guo, S Gould, A Cox, D Griffin
Viral Immunology 2022
Comprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals
S Gil-Manso, I Blanco, R López-Esteban, D Carbonell, L López-Fernández, L West, R Correa-Rocha, M Pion
Frontiers in immunology 2022
Formation and Expansion of Memory B Cells against Coronavirus in Acutely Infected COVID-19 Individuals
A Embong, P Nguyen-Contant, J Wang, P Kanagaiah, F Chaves, T Fitzgerald, Q Zhou, G Kosoy, A Branche, B Miller, M Zand, M Sangster, D Topham
Pathogens 2022
The Impact of SARS-CoV-2 Primary Vaccination in a Cohort of Patients Hospitalized for Acute COVID-19 during Delta Variant Predominance
D Stupica, S Collinet-Adler, N Kejžar, Z Jagodic, M Poljak, M Klevišar
Journal of Clinical Medicine 2022
COVID-19 Infection in Children: Diagnosis and Management
F Zhu, J Ang
Current Infectious Disease Reports 2022
Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
Ao L, Lu T, Cao Y, Chen Z, Wang Y, Li Z, Ren X, Xu P, Peng M, Chen M, Zhang G, Xiang D, Cai D, Hu P, Shi X, Zhang D, Ren H
Emerging Microbes & Infections 2022
The prevalence of adaptive immunity to COVID-19 and reinfection after recovery - a comprehensive systematic review and meta-analysis.
Chivese T, Matizanadzo JT, Musa OAH, Hindy G, Furuya-Kanamori L, Islam N, Al-Shebly R, Shalaby R, Habibullah M, Al-Marwani TA, Hourani RF, Nawaz AD, Haider MZ, Emara MM, Cyprian F, Doi SAR
Pathogens and Global Health 2022
Waning humoral immune responses to inactivated SARS-CoV-2 vaccines in patients with severe liver disease.
Chen Z, Zhang Y, Song R, Wang L, Hu X, Li H, Cai D, Hu P, Shi X, Ren H
Signal Transduction and Targeted Therapy 2022
COVID-19 and plasma cells: Is there long-lived protection?
Nguyen DC, Lamothe PA, Woodruff MC, Saini AS, Faliti CE, Sanz I, Lee FE
Immunological Reviews 2022
A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses.
Torresi J, Edeling MA, Nolan T, Godfrey DI
Frontiers in immunology 2022
Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2
Zheng J, Miao J, Guo R, Guo J, Fan Z, Kong X, Gao R, Yang L
Frontiers in Cellular and Infection Microbiology 2022
The role of interleukin-22 in lung health and its therapeutic potential for COVID-19
Fang S, Ju D, Lin Y, Chen W
Frontiers in immunology 2022
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
Karger AB, Brien JD, Christen JM, Dhakal S, Kemp TJ, Klein SL, Pinto LA, Premkumar L, Roback JD, Binder RA, Boehme KW, Boppana S, Cordon-Cardo C, Crawford JM, Daiss JL, Dupuis AP II, Espino AM, Firpo-Betancourt A, Forconi C, Forrest JC, Girardin RC, Granger DA, Granger SW, Haddad NS, Heaney CD, Hunt DT, Kennedy JL, King CL, Krammer F, Kruczynski K, LaBaer J, Lee FE, Lee WT, Liu SL, Lozanski G, Lucas T, Mendu DR, Moormann AM, Murugan V, Okoye NC, Pantoja P, Payne AF, Park J, Pinninti S, Pinto AK, Pisanic N, Qiu J, Sariol CA, Simon V, Song L, Steffen TL, Stone ET, Styer LM, Suthar MS, Thomas SN, Thyagarajan B, Wajnberg A, Yates JL, Sobhani K
mSphere 2022
A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects
Dotiwala F, Upadhyay AK
Frontiers in immunology 2022
Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases
Li H, Wang Y, Ao L, Ke M, Chen Z, Chen M, Peng M, Ling N, Hu P, Cai D, Zhang D, Ren H
Frontiers in immunology 2022
Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer
Song R, Liu L, Pan Q, Liu J, Tan J, Deng J, Deng Q, Lin Z, Chen M, Peng M, Ren H, Ming J
Frontiers in immunology 2022
Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives
Zhu Q, Xu Y, Wang T, Xie F
Frontiers in immunology 2022
Weakened humoral and cellular immune response to the inactivated COVID-19 vaccines in Chinese individuals with obesity/overweight
Zhu Q, Zhang Y, Kang J, Chen Z, Peng M, Chen M, Zhang G, Xiang D, Xiao S, Li H, Mei Y, Yang J, Qi X, Cai D, Ren H
Genes & Diseases 2022
Safety and immunogenicity of inactivated COVID-19 vaccine in patients with metabolic syndrome: A cross-sectional observational study
Guo Q, Yang L, Peng R, Gao T, Chu X, Jiang D, Ke D, Ren H
Frontiers in public health 2022
High activation levels maintained in receptor‐binding domain–specific memory B cells in people with severe coronavirus disease 2019
Gupta M, Balachandran H, Louie RH, Li H, Agapiou D, Keoshkerian E, Christ D, Rawlinson W, Mina MM, Post JJ, Hudson B, Gilroy N, Konecny P, Bartlett AW, Sasson SC, Ahlenstiel G, Dwyer D, Lloyd AR, Martinello M, Luciani F, Bull RA
Immunology and Cell Biology 2022
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization.
Karger AB, Brien JD, Christen JM, Dhakal S, Kemp TJ, Klein SL, Pinto LA, Premkumar L, Roback JD, Binder RA, Boehme KW, Boppana S, Cordon-Cardo C, Crawford JM, Daiss JL, Dupuis AP 2nd, Espino AM, Firpo-Betancourt A, Forconi C, Forrest JC, Girardin RC, Granger DA, Granger SW, Haddad NS, Heaney CD, Hunt DT, Kennedy JL, King CL, Krammer F, Kruczynski K, LaBaer J, Lee FE, Lee WT, Liu SL, Lozanski G, Lucas T, Mendu DR, Moormann AM, Murugan V, Okoye NC, Pantoja P, Payne AF, Park J, Pinninti S, Pinto AK, Pisanic N, Qiu J, Sariol CA, Simon V, Song L, Steffen TL, Stone ET, Styer LM, Suthar MS, Thomas SN, Thyagarajan B, Wajnberg A, Yates JL, Sobhani K
medRxiv : the preprint server for health sciences 2022
Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG
S Winklmeier, K Eisenhut, D Taskin, H Rübsamen, R Gerhards, C Schneider, PR Wratil, M Stern, P Eichhorn, OT Keppler, M Klein, S Mader, T Kümpfel, E Meinl
iScience 2021
SARS-CoV-2 spike-specific memory B cells express higher levels of T-bet and FcRL5 after non-severe COVID-19 as compared to severe disease
RA Reyes, K Clarke, SJ Gonzales, AM Cantwell, R Garza, G Catano, RE Tragus, TF Patterson, S Bol, EM Bunnik, MC van Zelm
PloS one 2021
Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model
S Dhakal, CA Ruiz-Bedoya, R Zhou, PS Creisher, JS Villano, K Littlefield, JR Castillo, P Marinho, AE Jedlicka, AA Ordonez, M Bahr, N Majewska, MJ Betenbaugh, K Flavahan, AR Mueller, MM Looney, D Quijada, F Mota, SE Beck, J Brockhurst, AM Braxton, N Castell, M Stover, FR DAlessio, KA Pate, PC Karakousis, JL Mankowski, A Pekosz, SK Jain, SL Klein, CB Coyne
mBio 2021
Elevated cytokines and chemokines in peripheral blood of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma
SL Fanning, R Korngold, Z Yang, K Goldgirsh, S Park, J Zenreich, M Baker, P McKiernan, M Tan, B Zhang, ML Donato, DS Perlin, SR Shih
PLoS pathogens 2021
Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?
ME Ligotti, F Pojero, G Accardi, A Aiello, C Caruso, G Duro, G Candore
Frontiers in Cell and Developmental Biology 2021
Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion
OF Wirz, K Röltgen, BA Stevens, S Pandey, MK Sahoo, L Tolentino, M Verghese, K Nguyen, M Hunter, TT Snow, AR Singh, CA Blish, JR Cochran, JL Zehnder, KC Nadeau, BA Pinsky, TD Pham, SD Boyd
Frontiers in immunology 2021
Emergency seed funding for COVID-19 research: lessons from Johns Hopkins University
J Messersmith, C Stoddart-Osumah, M Lennon, D Wirtz
Journal of Clinical Investigation 2021
Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation
LM Meyers, AH Gutiérrez, CM Boyle, F Terry, BG McGonnigal, A Salazar, MF Princiotta, WD Martin, AS Groot, L Moise
npj Vaccines 2021
Immunity to SARS‐CoV‐2 induced by infection or vaccination
XC Dopico, S Ols, K Loré, GB Hedestam
Journal of Internal Medicine 2021
Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU
L Vigón, J García-Pérez, S Rodríguez-Mora, M Torres, E Mateos, MC de la Osa, M Cervero, RM Molina, C Navarro, MA Murciano-Antón, V García-Gutiérrez, V Planelles, J Alcamí, M Pérez-Olmeda, M Coiras, MR López-Huertas
Frontiers in immunology 2021
Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
P Ahluwalia, K Vaibhav, M Ahluwalia, AK Mondal, N Sahajpal, AM Rojiani, R Kolhe
Frontiers in immunology 2021
Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection
PP Sfikakis, KM Verrou, G Ampatziadis-Michailidis, O Tsitsilonis, D Paraskevis, E Kastritis, E Lianidou, P Moutsatsou, E Terpos, I Trougakos, V Chini, M Manoloukos, P Moulos, GA Pavlopoulos, G Kollias, P Hatzis, MA Dimopoulos
Frontiers in immunology 2021
The germinal centre B cell response to SARS-CoV-2
BJ Laidlaw, AH Ellebedy
Nature Reviews Immunology 2021
Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
HM Kantarjian, G Zugmaier, M Brüggemann, BL Wood, HA Horst, Y Zeng, G Martinelli
Cancers 2021
SARS-CoV-2–specific B- and T-cell immunity in a population-based study of young Swedish adults
S Björkander, L Du, F Zuo, S Ekström, Y Wang, H Wan, N Sherina, L Schoutens, J Andréll, N Andersson, A Georgelis, A Bergström, H Marcotte, I Kull, L Hammarström, E Melén, Q Pan-Hammarström, C Almqvist, N Andersson, N Ballardini, A Bergström, S Björkander, P Brodin, A Castel, S Ekström, A Georgelis, L Hammarström, Q Pan-Hammarström, J Hallberg, C Jansson, M Kere, I Kull, A Lauber, A Lövquist, E Melén, J Mjösberg, I Mogensen, L Palmberg, G Pershagen, N Roxhed, J Schwenk
Journal of Allergy and Clinical Immunology 2021
Dynamics of SARS-CoV-2-specific antibodies among COVID19 biobank donors in Argentina
Y Longueira, ML Polo, G Turk, N Laufer
Heliyon 2021
Immunologisch relevante Aspekte der neuen COVID-19-Impfstoffe: Ein Positionspapier der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI) und des Ärzteverbands Deutscher Allergologen (AeDA)
E Untersmayr, E Förster-Waldl, M Bonelli, K Boztug, PM Brunner, T Eiwegger, K Eller, L Göschl, K Grabmeier-Pfistershammer, W Hötzenecker, G Jordakieva, AR Moschen, B Pfaller, W Pickl, W Reinisch, U Wiedermann, L Klimek, KC Bergmann, R Brehler, N Novak, HF Merk, U Rabe, WW Schlenter, J Ring, W Wehrmann, NK Mülleneisen, H Wrede, T Fuchs, E Jensen-Jarolim
Allergo Journal 2021
Immunologically relevant aspects of the new COVID-19 vaccines—an ÖGAI (Austrian Society for Allergology and Immunology) and AeDA (German Society for Applied Allergology) position paper
E Untersmayr, E Förster-Waldl, M Bonelli, K Boztug, PM Brunner, T Eiwegger, K Eller, L Göschl, K Grabmeier-Pfistershammer, W Hötzenecker, G Jordakieva, AR Moschen, B Pfaller, W Pickl, W Reinisch, U Wiedermann, L Klimek, KC Bergmann, R Brehler, W Pfützner, N Novak, H Merk, U Rabe, W Schlenter, J Ring, W Wehrmann, N Mülleneisen, H Wrede, T Fuchs, E Jensen-Jarolim
Allergo Journal International 2021
Mesenchymal stem cell therapy for severe COVID-19
L Shi, L Wang, R Xu, C Zhang, Y Xie, K Liu, T Li, W Hu, C Zhen, FS Wang
Signal Transduction and Targeted Therapy 2021
Impact of reproduction number on the multiwave spreading dynamics of COVID-19 with temporary immunity: A mathematical model
B Shayak, MM Sharma, M Gaur, AK Mishra
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2021
Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients Undergoing Serial Laboratory Testing
A Qureshi, W Baskett, W Huang, I Lobanova, S Naqvi, C Shyu
Clinical Infectious Diseases 2021
ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2
Gil-Manso S, Miguens Blanco I, Motyka B, Halpin A, López-Esteban R, Pérez-Fernández VA, Carbonell D, López-Fernández LA, West L, Correa-Rocha R, Pion M
Virulence 2021
Advances in understanding the formation and fate of B-cell memory in response to immunization or infection.
Kealy L, Good-Jacobson KL
2021
SARS-CoV-2 spike-specific memory B cells express markers of durable immunity after non-severe COVID-19 but not after severe disease.
Reyes RA, Clarke K, Gonzales SJ, Cantwell AM, Garza R, Catano G, Tragus RE, Patterson TF, Bol S, Bunnik EM
bioRxiv : the preprint server for biology 2021

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Blogged by 1
Referenced in 1 policy sources
Posted by 36 X users
On 1 Facebook pages
169 readers on Mendeley
See more details